An international team of researchers identified all drug trials registered in ClinicalTrials.gov between 2006 and 2011 and tracked the resulting publications, finding that although 60% of the disease burden was attributable to children, only 12% of trials were pediatric. This may be, the authors say, a product of pediatric trials’ greater reliance on governmental and nonprofit funding (60%), in contrast to adult trials’ 65% reliance on industry funding. Results appeared in Pediatrics, online July 23, 2012.
Abstract → Bourgeois, F., Murthy, S., “Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden” Pediatrics, online July 23, 2012 (doi: 10.1542/peds.2012-0139)
Related Item:
How Psych Drug Studies Shortchange Kids
